Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious complications in chronic lymphoid malignancy.

G Egerer1, M Hensel, A D Ho

  • 1Department of Internal Medicine V, University of Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary

Preventing infections in chronic lymphocytic leukemia (CLL) patients is vital. Prophylactic co-trimoxazole is recommended with steroids or during neutropenia, while herpes zoster prophylaxis is for severely depleted CD4 counts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem‑ion): Interim report of a randomized phase II pilot trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

ESMO open·2025
Same author

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.

BMC cancer·2022
Same author

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Immunohematology·2021
Same author

Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.

Trials·2021

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Background:

  • Infection prevention is a significant challenge for patients with chronic lymphoid malignancies, particularly chronic lymphocytic leukemia (CLL).
  • Increased survival rates in CLL necessitate improved strategies for managing and preventing infections.
  • Identifying patients at high risk for infection remains difficult.

Purpose of the Study:

  • To review current strategies for infection prevention in patients with chronic lymphoid malignancies.
  • To provide guidance on the use of prophylactic antibiotics and antiviral agents.
  • To discuss the role of immunoglobulin replacement therapy.

Main Methods:

  • Review of existing literature and clinical guidelines on infection prevention in CLL.

Related Experiment Videos

  • Analysis of data regarding prophylactic antibiotic use (co-trimoxazole) and antiviral prophylaxis (herpes zoster).
  • Evaluation of criteria for immunoglobulin replacement therapy.

    • Main Results:

    • Co-trimoxazole is recommended for CLL patients requiring steroids, with documented early infections, or during neutropenia.
    • Severely depleted CD4 counts (<50 cells/mL) may indicate a need for herpes zoster prophylaxis.
    • Intravenous immunoglobulin (Ig) replacement is considered for hypogammaglobulinemia (IgG < 400 mg/dL) with recurrent severe infections.

    Conclusions:

    • Proactive infection management, including judicious use of prophylactic antibiotics and antivirals, is crucial for CLL patients.
    • Further research is needed to establish optimal protocols for prophylaxis and immunoglobulin therapy.
    • Risk stratification for infection in CLL patients requires further refinement.